Your Site Initiation Visits Done RightAs a Project Manager (PM) working closely with Clinical Research Associates (CRAs) to manage Site Initiation Visits (SIVs), I understand how pivotal these meetings are, as they set the tone for the entire [...]
Transforming Struggling Expanded Access and Post-Trial Access Programs Expanded Access (EAP) and Post-Trial Access (PTA) programs are inherently complex. Even the most carefully designed initiatives can face unforeseen challenges as they progress. In these moments, Sponsors [...]
What are Expanded Access and Post-Trial Access Programs? Expanded access (EAP) and Post-Trial Access (PTA) programs allow eligible patients to receive investigational therapies outside the traditional clinical trial setting. Expanded access focuses on providing investigational treatment [...]
As the clinical research landscape progresses, so do the expectations of regulators. The U.S. Food and Drug Administration (FDA) has made it clear: real-world data (RWD) has the potential to enhance the efficiency and relevance [...]
Access to unlicensed or investigational medicines outside of clinical trials prior to marketing authorization plays a critical role in addressing urgent, unmet clinical needs in patient populations. Within the European Union (EU), such access is [...]
At first glance, choosing a low-cost vendor to manage your access program may seem like the most practical business decision. However, some Sponsors quickly find that the “low-cost” option results in higher long-term expenses, lack [...]
In the ever-evolving and increasingly complex clinical landscape, mobile nursing services have become a cornerstone of clinical research efforts. But not all mobile nursing models are created equal. At WEP, we made the strategic decision [...]
In the evolving world of clinical research, one reality remains unchanged: running a successful clinical trial is hard. Recruitment lags, retention falters, sites are stretched thin, and access remains unequal. At the heart of these [...]
In clinical research, the relationship between the Site and the CRO - more specifically, the Site and the CRA - is the foundation of any smooth running project. As a former Clinical Research Coordinator (CRC) [...]
Early Access Programs (EAPs) in France provide pharmaceutical and biotech companies with a valuable opportunity to offer patients innovative treatments before obtaining formal marketing authorization. Regulated by the French National Agency for the Safety of [...]
